The effect of antibiotic (Abx) use on immune checkpoint inhibitor (ICI) efficacy in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.

Authors

null

Ubenthira Patgunarajah

Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Ubenthira Patgunarajah , Scott Dawsey , Nikhil Pramod , Kimberly Maroli , Moshe Chaim Ornstein , Christopher Eing Wee , Timothy D. Gilligan , Allison Martin , Amanda Nizam , Omar Y. Mian , Wei Wei , C. Marcela Diaz-Montero , Paul G. Pavicic Jr., Jane Nguyen , Shilpa Gupta

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Urothelial Cancer - Advanced/Metastatic Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4580)

DOI

10.1200/JCO.2023.41.16_suppl.4580

Abstract #

4580

Poster Bd #

72

Abstract Disclosures